Renal macrophage migration and crystal phagocytosis via inflammatory-related gene expression during kidney stone formation and elimination in mice: Detection by association analysis of stone-related gene expression and microstructural observation

Journal of Bone and Mineral Research

Volumn 25, Issue 12, 2010, Pages 2701-2711

  Okada, Atsushi ^a   Yasui, Takahiro ^a   Fujii, Yasuhiro ^a   Niimi, Kazuhiro ^a   Hamamoto, Shuzo ^a   Hirose, Masahito ^a   Kojima, Yoshiyuki ^a   Itoh, Yasunori ^a   Tozawa, Keiichi ^a   Hayashi, Yutaro ^a   Kohri, Kenjiro ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Chemokines; Kidney Stone Model Mice; Macrophage; Microarray Pathway Analysis; Phagocytosis

Indexed keywords

CD44V ANTIGEN; COLONY STIMULATING FACTOR 1; CXCL1 CHEMOKINE; FIBRONECTIN; GLYOXYLIC ACID; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHOSPHOPROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL STRUCTURE; CRYSTALLIZATION; DNA MICROARRAY; GENE EXPRESSION; GENE STRUCTURE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY CELL; MACROPHAGE; MALE; MONOCYTE; MOUSE; NEPHROLITHIASIS; NONHUMAN; PHAGOCYTOSIS; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 78649624237     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.158     Document Type: Article

References (43)

1. Rodgers AL, De Klerk DP., Crystalluria and urolithiasis in a relatively stone-free population. Scan Electron Microsc. 1986; 3: 1157-1167.
2. Asplin JR, Parks JH, Coe FL., Dependence of upper limit of metastability on supersaturation in nephrolithiasis. Kidney Int. 1997; 52: 1602-1608.
3. Kohri K, Suzuki Y, Yoshida K, et al. Molecular cloning and sequencing of cDNA encoding urinary stone protein, which is identical to osteopontin. Biochem Biophys Res Commun. 1992; 184: 859-864.
4. Umekawa T, Yamate T, Amasaki N, Kohri K, Kurita T., Osteopontin mRNA in the kidney on an experimental rat model of renal stone formation without renal failure. Urol Int. 1995; 55: 6-10.
5. Tawada T, Fujita K, Sakakura T, et al. Distribution of osteopontin and calprotectin as matrix protein in calcium-containing stone. Urol Res. 1999; 27: 238-242.
6. Yasui T, Fujita K, Asai K, Kohri K., Osteopontin regulates adhesion of calcium oxalate crystals to renal epithelial cells. Int J Urol. 2002; 9: 100-108.
7. Yamate T, Kohri K, Umekawa T, Iguchi M, Kurita T., Osteopontin antisense oligonucleotide inhibits adhesion of calcium oxalate crystals in Madin-Darby canine kidney cell. J Urol. 1998; 160: 1506-1512.
8. Okada A, Nomura S, Saeki Y, et al. Morphological conversion of calcium oxalate crystals into stones is regulated by osteopontin in mouse kidney. J Bone Miner Res. 2008; 23: 1629-1637.
9. Hamamoto S, Nomura S, Yasui T, et al. Effects of Impaired Functional Domains of Osteopontin on Renal Crystal Formation: Analyses of OPN-Transgenic and OPN-Knockout Mice. J Bone Miner Res. 2009; 19. [Epub ahead of print]
10. Hunter GK, Kyle CL, Goldberg HA., Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyappatite formation. Biochem J. 1994; 300: 723-728.
11. Asplin JR, Arsenault D, Parks JH, Coe FL, Hoyer JR., Contribution of human uropontin to inhibition of calcium oxalate crystallization. Kidney Int. 1998; 53: 194-199.
12. Wesson JA, Johnson RJ, Mazzali M, Beshensky AM, Stietz S, Giachelli C., Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J Am Soc Nephrol. 2003; 14: 139-147.
13. Okada A, Nomura S, Saeki Y, et al. Successful formation of calcium oxalate stone in mouse kidney by the injection of glyoxylate intraperitoneally. Urol Res. 2007; 35: 89-99.
14. Vervaet BA, Verhulst A, Dauwe SE, De Broe ME, D'Haese PC., An active renal crystal clearance mechanism in rat and man. Kidney Int. 2009; 75: 41-51.
15. Okada A, Yasui T, Hamamoto S, et al. Genome-wide analysis of genes related to kidney stone formation and elimination in the calcium oxalate nephrolithiasis model mouse: detection of stone-preventive factors and involvement of macrophage activity. J Bone Miner Res. 2009; 24: 908-924.
16. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC, Conklin BR., GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet. 2002; 31: 19-20.
17. Pizzolato P., Histochemical recognition of calcium oxalate. J Histochem Cytochem. 1964; 12: 333-336.
18. Nishino I, Amizuka N, Ozawa H., Histochemical examination of osteoblastic activity in op/op mice with or without injection of recombinant M-CSF. J Bone Miner Metab. 2001; 19: 267-276.
19. Ghazali A, Fuent V, Desaint C, et al. Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab. 1997; 82: 32-38.
20. Lundahl J, Sköld CM, Halldén G, Hallgren M, Eklund A., Monocyte and neutrophil adhesion to matrix proteins is selectively enhanced in the presence of inflammatory mediators. Scand J Immunol. 1996; 44: 143-149.
21. Boisvert WA, Santiago R, Curtiss LK, Terkeltaub RA., A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest. 1998; 15: 353-363.
22. Kusaka M, Kuroyanagi Y, Mori T, et al. Up-regulation of osteopontin, chemokines, adhesion molecule, and heat shock proteins in 1-hour biopsy from cardiac death donor kidneys. Transplant Proc. 2006; 38: 3347-3350.
23. Bennett MR, Czech KA, Arend LJ, Witte DP, Devarajan P, Potter SS., Laser capture microdissection-microarray analysis of focal segmental glomerulosclerosis glomeruli. Nephron Exp Nephrol. 2007; 107: e30-40.
24. Erreni M, Bianchi P, Laghi L, et al. Expression of chemokines and chemokine receptors in human colon cancer. Methods Enzymol. 2009; 460: 105-121.
25. de Water R, Noordermeer C, Houtsmuller AB, et al. Role of macrophages in nephrolithiasis in rats: an analysis of the renal interstitium. Am J Kidney Dis. 2000; 36: 615-625.
26. Blom AB, van Lent P, Libregt S, et al. Crucial role of macrophages in matrix metalloproteinase- mediated cartilage destruction. Arthritis Rheum. 2007; 56: 147-157.
27. Martignetti JA, Aqeel AA, Sewairi WA, et al. Mutation of the mayrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nature Genetics. 2001; 28: 261-265.
28. Lyon M, Rushton G, Askari JA, Humphries MJ, Gallagher JT., Elucidation of the structural features of heparan sulfate important for interaction with the Hep-2 domain of fibronectin. J Biol Chem. 2000; 275: 4599-4606.
29. Tsujikawa K, Tsujihata M, Tei N, Yoshimura K, Nonomura N, Okuyama A., Elucidation of the mechanism of crystal-cell interaction using fibronectin-overexpressing Madin-Darby canine kidney cells. Urol Int. 2007; 79: 157-163.
30. Vernon-Wilson EF, Auradé F, Brown SB., CD31 promotes beta1 integrin-dependent engulfment of apoptotic Jurkat T lymphocytes opsonized for phagocytosis by fibronectin. J Leukoc Biol. 2006; 79: 1260-1267.
31. Kramer G, Steiner GE, Prinz-Kashani M, Bursa B, Marberger M., Cell-surface matrix proteins and sialic acids in cell-crystal adhesion; the effect of crystal binding on the viability of human CAKI-1 renal epithelial cells. BJU Int. 2003; 91: 554-559.
32. Toblli JE, Angerosa M, Stella I, Ferder L, Inserra F., Urinary calcium oxalate supersaturation beyond nephrolithiasis. Relationship with tubulointerstitial damage. Medicina (B Aires). 2003; 63: 97-104.
33. Umekawa T, Chegini N, Khan SR., Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells. Kidney Int. 2002; 61: 105-112.
34. de Water R, Noordermeer C, van der Kwast TH, et al. Calcium oxalate nephrolithiasis: effect of renal crystal deposition on the cellular composition of the renal interstitium. Am J Kidney Dis. 1999; 33: 761-771.
35. Asselman M, Verhulst A, De Broe ME, Verkoelen CF., Calcium oxalate crystal adherence to hyaluronan-, osteopontin-, and CD44-expressing injured/regenerating tubular epithelial cells in rat kidneys. J Am Soc Nephrol. 2003; 14: 3155-3166.
36. Vachon E, Martin R, Plumb J, et al. CD44 is a phagocytic receptor. Blood. 2006; 15: 4149-4158.
37. Vachon E, Martin R, Kwok V, et al. CD44-mediated phagocytosis induces inside-out activation of complement receptor-3 in murine macrophages. Blood. 2007; 15: 4492-4502.
38. Kaartinen MT, Murshed M, Karsenty G, McKee MD., Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice. J Histochem Cytochem. 2007; 55: 375-386.
39. Gao B, Yasui T, Itoh Y, Tozawa K, Hayashi Y, Kohri K., A polymorphism of matrix Gla protein gene is associated with kidney stones. J Urol. 2007; 177: 2361-2365.
40. Kaneko K, Yamanobe T, Onoda M, Mawatari K, Nakagomi K, Fujimori S., Analysis of urinary calculi obtained from a patient with idiopathic hypouricemia using micro area x-ray diffractometry and LC-MS. Urol Res. 2005; 33: 415-421.
41. Lebman D, Edmiston J., The role of TGF-beta in growth, differentiation, and maturation of B lymphocytes. Microbes Infect. 1999; 1: 1297-1304.
42. Tsujihata M, Momohara C, Yoshioka I, Tsujimura A, Nonomura N, Okuyama A., Atorvastatin inhibits renal crystal retention in a rat stone forming model. J Urol. 2008; 180: 2212-2217.
43. Mizuguchi Y, Miyajima A, Kosaka T, Asano T, Asano T, Hayakawa M., Atorvastatin ameliorates renal tissue damage in unilateral ureteral obstruction. J Urol. 2004; 172: 2456-2459.